 | Up a level |
Back, David, Belperio, Pamela, Bondin, Mark, Negro, Francesco, Talal, Andrew H, Park, Caroline, Zhang, ZhenZhen, Pinsky, Brett, Crown, Eric, Mensa, Federico J et al (show 1 more authors)
(2019)
Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis.
JOURNAL OF VIRAL HEPATITIS, 26 (8).
pp. 951-960.
Bourgeois, Stefan, Curescu, Manuela G, Larrey, Dominique G, Marra, Fiona 
ORCID: 0000-0003-1326-1149, Dorr, Patrick, Charafeddine, Mariem, Crown, Eric, Bondin, Mark and Back, David J
(2017)
Impact of Comorbidities and Comedications on the Effectiveness of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir ± Ribavirin in Clinical Practice: Real-World Evidence From a Multicountry Postmarketing Observational Study.
.
Ferenci, Peter, Bourgeois, Stefan, Buggisch, Peter, Norris, Suzanne, Curescu, Manuela, Larrey, Dominique, Marra, Fiona ORCID: 0000-0003-1326-1149, Kleine, Henning, Dorr, Patrick, Charafeddine, Mariem et al (show 4 more authors)
(2019)
Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in hepatitis C virus genotype 1-and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational studies from 13 countries.
JOURNAL OF VIRAL HEPATITIS, 26 (6).
pp. 685-696.